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1. Introduction 
Hearing loss affects all demographics regardless of geographical location or age. In a similar 
fashion to how hearing loss can isolate post-lingualy deaf adults, hearing loss in the 
pediatric population has profound detrimental effects despite the richness of the deaf 
culture. A complete discussion of the adverse effects of hearing loss must include discussion 
of this important component of the deaf and hearing impaired population. The World 
Health Organization defines “disabling hearing impairment” in children under the age of 15 
years as an unaided hearing threshold level in the better ear of 31 dB HL or more using pure 
tone averages at 0.5, 1, 2 and 4 kHz. The prevalence of childhood hearing loss is 1.2 to 1.7 
cases per 1000 live births and the prevalence increases up to 6 years of age as a result of 
meningitis, delayed onset of genetic hearing loss, or delayed diagnosis (Kral & O'Donoghue, 
2010). In the majority of cases of childhood  hearing loss is congenital with a smaller 
proportion being progressive or acquired (A. Davis & Wood, 1992; A. Davis et al., 1997).The 
prevalence is greater still in developing countries because of lack of immunization, exposure 
to ototoxic drugs, and consanguinity (Kral & O'Donoghue, 2010). Profound hearing loss 
(hearing loss > 90 dB) has far-reaching, lifelong consequences in children (Kral & O'Donoghue, 
2010). Andrej et al. report that there can be a restriction in learning and literacy as a result of 
the lack of development of spoken language with its impact on daily communication (Kral & 
O'Donoghue, 2010; Marschark & Wauters, 2008). This in turn has been shown to substantially 
compromise educational achievement and employment opportunity later in life (Allen, 1986; 
A. Davis et al., 1997; Schroeder et al., 2006; Thompson et al., 2001; Wake, Hughes, Poulakis, 
Collins, & Rickards, 2004a). The detrimental effects of profound hearing loss in children are 
summarized in Table 1. Unless children are afforded opportunities to develop language, deaf 
children can fall behind their hearing peers in communication, cognition, literacy and 
psychosocial development (Holden-Pitt & Albertorio, 1998).  
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Speech and language development 
Academic achievement 
Social-emotional development 
Childhood behavioral problems 
Comprised employment opportunities in later life 
Self-perceived health status 
*(Allen, 1986; A. Davis et al., 1997; Kral & O'Donoghue, 2010; Marschark & Wauters, 2008; Schroeder 
et al., 2006; Thompson et al., 2001; Wake, Hughes, Poulakis, Collins, & Rickards, 2004a) 
Table 1. Detrimental Effects of Profound Hearing Loss in Childhood* 
The widespread use of universal neonatal hearing screening has been established based on 
the growing body of evidence that early detection of hearing loss leads to early aural 
rehabilitation (Kennedy, McCann, Campbell, Kimm, & Thornton, 2005). Multiple studies 
have demonstrated the deleterious effect of bilateral hearing loss on speech and language 
development (Allen, 1986; A. Davis et al., 1997; Thompson et al., 2001; Wake, Hughes, 
Poulakis, Collins, & Rickards, 2004b). However if caught early, the effects of hearing loss are 
somewhat mitigated. Yoshinaga-Itano et al. reported on the ability of early detection of 
hearing loss to improve language development as measured by standardized testing 
(Yoshinaga-Itano, Sedey, Coulter, & Mehl, 1998; Yoshinaga-Itano, 2003). Children enrolled 
into language programs at earlier ages have improved vocabulary and verbal reasoning 
skills on standardized tests at 5 years of age (Moeller, 2000) Opponents to Universal 
screening cite the great cost of such widespread screening as well as efficacy in earlier years. 
From a pragmatic, fiduciary perspective, a cost-effectiveness study has shown that as a 
result of special education needs, failure to detect severe-to-profound hearing loss can cost 
the educational system  approximately $38 000 – 240 000 (USD) per child over their 
educational lifetime (Mohr et al., 2000). It would seem then that detecting these children 
would offset a significant amount of the cost. Furthermore, in areas that have adapted a 
Universal Newborn Hearing protocol, detection of congenital hearing loss has nearly 
doubled since its introduction (Choo & Meinzen-Derr, 2010). 
It is clear that the early detection of hearing loss has strong developmental, psychosocial and 
societal implications as well. Therefore, in 2007 the American Academy of Pediatrics’ Joint 
Committee on Infant hearing endorsed the early detection of hearing loss with an aim at 
early intervention to improve linguistic competence and literary development (Busa et al., 
2007). They recommended that all infants should be screened prior to 1 month of age. 
Children identified with hearing loss by screening should have a comprehensive 
audiological assessment by 3 months of age. After audiological assessment, children with 
confirmed hearing loss should receive appropriate intervention by dedicated hearing loss 
health care and education professionals not later than 6 months of age. Children with risk 
factors for hearing loss (a summary of commonly cited risk factors can be found in Table 2.) 
should be followed by on-going surveillance starting at 2 months of age. Unfortunately in 
many centers the “lost to follow up” rates approach 40% of infants who do not pass their 
infant screening (Choo & Meinzen-Derr, 2010). All centers must work diligently to ensure 
children who fail their hearing screen are referred appropriately to maximize their potential 
and mitigate the lifelong effects of hearing loss. The following sections will provide an 
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overview of existing neonatal hearing screening tests and use of the medial olivocochlear 
system as a potential new screening method. 
 
Craniofacial syndromes: Crouzon disease, Klippel-Feil syndrome, and Goldenhar 
syndrome 
Syndromes known to be associated with sensorineural hearing loss: Brancho-oto-renal 
syndrome, Pendred syndrome, Wardenburg syndrome, Treacher-Collins, Stickler 
syndrome, Usher syndrome 
Neurodegenerative disorders: Hunter syndrome, Friedrich’s ataxia, Charcot-Marie-
Tooth syndrome 
Trauma 
Extracorporeal membrane oxygenation   
Chemotherapy 
Consanguinity 
Family history of hearing loss 
Neonatal hyperbilirubinemia 
Neonatal intensive care unit admission for > 5 days 
Infection and neonatal sepsis: CMV, measles, mumps, rubella, H influenzae type b, and 
childhood meningitis, toxoplasmosis, herpes, syphilis, bacterial meningitis 
Genetic mutations 
*(Busa et al., 2007; Manchaiah, Zhao, Danesh, & Duprey, 2011) 
Table 2. Risk factors for childhood hearing loss* 
2. Existing neonatal hearing tests 
The difficulty of testing young individuals using subjective methods has lead to the 
development of hearing testing based on objective methods such as otoacoustic emissions 
and auditory brainstem response testing (James, 2011; Thompson et al., 2001). 
2.1 Auditory evoked potentials 
Measurement of auditory evoked potentials (AEP) has been possible since the 1960s. AEPs 
represent electrical activity occurring along the length of the auditory pathway. They are 
typically described by their latency from the onset of the auditory stimulus: early (0 to 15 
milliseconds), middle (15 to 100 milliseconds) and late (100 to 500 milliseconds). Auditory 
brainstem responses (ABR) appear to be the most clinically useful early latency AEPs for 
detecting hearing loss in newborns and infants ( Hecox 1974). Hecox et al. first speculated on 
the use of Auditory Brainstem Responses (ABR) as an objective method of assessing infant 
hearing in 1974 (Hecox & Galambos, 1974). Measurement of ABR makes use of the 
summation of action potentials from the cochlear nerve to the inferior colliculus of the 
midbrain in response to a click stimulus applied to the test ear. Since that time the use of 
ABR has become a widely accepted method to assess auditory function and hearing 
sensitivity. The commonly cited advantages and disadvantages of ABR are summarized in 
Table 3. 
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Screening ABR utilizes a click or tone pip stimulus presented via a headphone or a 
transducer inserted into the subject’s ear. Click stimuli are commonly used and make use of 
a broad range of frequencies (1 – 6 kHz) but do not provide information about hearing in 
lower frequencies (Jacobson & Jacobson, 2004) . If necessary, tone pips can be used to 
acquire frequency specific information (Jacobson & Jacobson, 2004). The subject is prepared 
with three surface electrodes placed on the forehead and both mastoids or earlobes. The 
electrodes detect click or tone pip-induced action potentials that are generated in the 
cochlea. The signal is transmitted from along the cochlear nerve from the cochlear nucleus to 
the inferior colliculus. The amplitude of the action potential is measured in microvolts and 
averaged. The averaged potential is then plotted against time to create a waveform with 
characteristic peaks labeled I-VII (Table 4).  Only waves I and II correspond to true action 
potentials. Waves III-VII are thought to represent post-synaptic activity in the major 
brainstem auditory centres. Given the necessity of electrode placement and duration of 
approximately 15 minutes, sedation is often required (Kral & O'Donoghue, 2010). The 
morphology and latency of the wave form is compared to a normal wave form and a pass or 
fail result is generated. The sensitivity of ABR is generally quoted as 84-100% and the 
specificity is 99.7% (A. Davis et al., 1997; Hall, Smith, & Popelka, 2004; Llanes & Chiong, 2004).  
2.2 Otoacoustic emissions 
Initially hypothesized in 1948 by the theoretical physicist Thomas Gold and later confirmed 
by Kemp in 1978, Otoacoustic emissions (OAE) now provide an important non-invasive 
method of auditory testing (Gold, 1948; Kemp, 1978b). OAEs are acoustic signals generated 
by the activity of the outer hair cells of the cochlea that occur during normal hearing. 
Control of outer hair cell activity is intimately linked with the olivocochlear pathway and 
will be discussed further in later sections. In brief, the mechanical energy generated by the 
outer hair cells propagates backward to the tympanic membrane. Movements of the 
tympanic membrane in turn produce acoustic signals that can be detected by an extremely 
sensitive microphone placed in the external ear canal. The presence of OAEs demonstrates 
the presence of functional outer hair cells suggesting the presence of a cochlea which forms 
the basis of this screening method. Testing of OAEs is simple and efficient requiring 
approximately 10 minutes. Sensitivity and specificity of OAE testing for hearing impairment 
ranges from 76.9-98% and 90% respectively (A. Davis et al., 1997; Llanes & Chiong, 2004; 
Thompson et al., 2001). 
Different types of OAE can be detected but only some are useful in hearing testing (Saurini, 
Nola, & Lendvai, 2004). Spontaneous OAEs are obtained without any acoustic simulation. 
They are narrow band signals present in 40-70% of normal ears. Evoked OAEs are 
stimulated by acoustic signals and comprise a range of subtypes. Sustained frequency OAEs 
are obtained by continuous acoustic stimuli and are found in approximately 94% of people. 
Their measurement is typically complex and is not used very often. Transient OAEs are 
stimulated by clicks or tone bursts. Distortion Product OAEs (DPOAE)  are produced in 
response to the simultaneous presentation of two stimuli and can be found in up to 98% of 
normal hearing individuals. As suggested by the name, stimuli for DPOAE consist of the 
combination of two stimuli that vary by frequency (f1 and f2) and intensity (L1 and L2). 
Varying the relationship of f1 and f2 and L1 and L2 determine the frequency response. 
Achieving an optimal response is usually obtained by setting L1 equal or greater than L2 e.g. 
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65 and 55 dBL SPL respectively are commonly used. Responses are usually the most robust 
when recorded at the frequency 2f1-f2.  Transient OAE testing applies a brief click to the test 
ear to elicit the hair cell response. As such, Transient OAE measurement lacks frequency 
specificity (Jacobson & Jacobson, 2004). Conversely, stimulus tones used in DPOAE testing 
combine frequency stimuli in a predictable way that can measure specific regions of the 
cochlea allowing frequency specific testing (Jacobson & Jacobson, 2004). While OAEs have 
been widely adapted for newborn hearing screening programs, they are still only surrogate 
markers for hearing. Their presence indicates normal function of the outer hair cell, middle 
ear and ear canal. As such, conditions such as auditory neuropathy, cochlear nerve 
hypoplasia or inner hair cell anomalies can be missed and may lead to delay in diagnosis 
and initiation of aural rehabilitation. 
 
 Advantage Disadvantage 
Otoacoustic 
Emissions 
Simple administration – 
minimal training required 
Only asses outer hair cell function 
Cost-effective Debris or fluid in the external ear 
may affect results 
Results are immediately 
available 
Failure rates are high during first 
24 hours after birth 
Average screening time is less 
than ABR 
No use in fluid filled middle ear 
 Requires quiet environment 
 Sensitivity – may fail to detect 
infants with very mild hearing 
loss or central auditory 
pathologies 
Automated 
auditory 
brainstem 
response 
Assess greater extent of 
auditory system 
Requires more operator 
knowledge than ABR 
Requires no interpretation by 
the screener 
ABR may be susceptible to 
electrical interference 
ABR results are less affected by 
middle ear or external ear 
debris than OAEs 
Sensitivity – may fail to detect 
Infants with very mild hearing 
loss 
Results are immediately 
available 
Requires long period of time 
May detect neural or central 
auditory pathologies 
Cost 
 May take longer in noisy 
environment 
 Patient must be sleeping 
 Potential for electrical and noise 
artifact 
Table 3. Advantages and Disadvantages of Existing Hearing screening methods 
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Wave I Action potential arising from afferent activity of cochlear nerve 
entering internal auditory canal 
Wave II Action potential arising from proximal cochlear nerve entering 
brainstem 
 
Wave III Arise from second order neurons beyond the cochlear nerve in the 
cochlear nucleus 
 
Wave IV Arise from third order neurons located in the superior olivary complex 
 
Wave V Multiple anatomic origins postulated in the vicinity of the inferior 
colliculus 
 
Wave VI Arise from medial geniculate body 
 
Wave VII Arise from medial geniculate body 
 
Table 4. Characteristic auditory brainstem response waves 
3. Auditory neuropathy spectrum disorder (ANSD) 
One disorder that continuously eludes the new born hearing screen is ANSD. ANSD 
represents a range of hearing disorders of variable severity which present with pure tone 
hearing thresholds that may be low or approach normal, but underestimate the subject’s 
perception of hearing difficulty. Included within the spectrum are inner hair cell anomalies, 
neuropathy of the auditory nerve, disruption of the olivocochlear response (OCR), and 
brainstem dysfunction that can be secondary to kernicterus (Amatuzzi et al., 2001; Berlin et 
al., 2005; Harrison, 1998; Hood & Berlin, 2001; Shapiro, 2003; Starr, Picton, Sininger, Hood, & 
Berlin, 1996; Yasunaga et al., 1999).The unifying feature of ANSD diseases are a 
characteristic finding of abnormal ABR waveforms in the presence of normal OAE and/or 
cochlear microphonic (CM). Middle ear muscle reflexes and the olivocochlear reponse are 
also absent. These findings are suggestive of persistent outer hair cell activity but lack of a 
normal afferent auditory pathway and as such would be missed by currently employed 
screening methods (Manchaiah et al., 2011). Accurate diagnosis is hampered by the lack of a 
simple commercially available test for OCR function but typically the diagnosis can be 
assumed from OAE and ABR results alone. 
Etiologies of ANSD that have been identified include polyneuropathy (especially in adults), 
perinatal anoxia and hypoxia, and hyperbilirubinaemia, congenital brain anomalies, 
ototoxic drug exposure, and genetic factors. An estimated 40% of cases have an underlying 
genetic basis, which can be inherited in both syndromic and non-syndromic conditions 
(Harrison, 2001; Manchaiah et al., 2011; Nadol Jr, 2001; Starr et al., 1996).  
Treatment options in ANSD include auditory verbal therapy, cued speech, hearing aids and 
cochlear implantation (Cone-Wesson, Rance, & Sininger, 2001; Rance & Barker, 2008a; Hood 
& Berlin, 2001). Prognostication and predicting treatment outcome is difficult and varies 
depending on origin. Some forms of neonatal ANSD can show significant spontaneous 
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improvement (Attias & Raveh, 2007; Rance & Barker, 2008b). As such determination of 
patient who will benefit from hearing aids or cochlear implantation is difficult (Raveh, 
Buller, Badrana, & Attias, 2007). The development of improved testing techniques that can 
be used to diagnose, characterize, and differentiate between the numerous diseases that 
make up this spectrum may allow patients to be treated earlier. 
4. The olivocochlear pathway  
4.1 Neuroanatomy and physiology 
Cochlear function including the sensitivity and frequency tuning of the peripheral auditory 
system is influenced by incoming acoustic stimuli but also higher cochlear function. The 
olivocochlear pathway is a neural pathway which innervates cochlear outer hair cells 
(OHC), linking the superior olivary complex to the cochlea. Further insights into this 
pathway may improve our ability to screen for various forms of hearing loss such as ANSD. 
The olivocochlear neural pathway is comprised of efferent neurons that travel from the 
superior olivary complex in the brainstem to cochlear hair cells. First described in 1946, 
Rasmussen (Rasmussen, 1946) traced the neural fibres from the floor of the fourth ventricle, 
along the inferior and superior vestibular nerves, then into the cochlear nerve in the bundle 
of Oort (the vestibulocochlear anastomosis). Later he confirmed passage of the pathway into 
the cochlea and named it the olivocochlear bundle (Rasmussen, 1953). This neural pathway, 
the olivocochlear efferent pathway, is now thought to play an important role in the 
olivocochlear reflex. There appear to be two forms of olivocochlear efferent fibres, medial 
olivocochlear (MOC) and lateral olivocochlear (LOC) efferents. The majority are the thin, 
unmyelinated fibres of the LOC system arising from the lateral superior olive and travel via 
the vestibular nerve to the cochlea where they innervate the auditory nerve supplying the 
inner hair cells (Kimura & Wersäll, 1962; Warr, 1975).  While the LOC system received 
contributions from both sides of the brainstem, the majority of fibres innervate the ipsilateral 
cochlea (Guinan Jr, 2006). Thick, myelinated neurons of the MOC pathway originate in the 
medial part of the superior olivary complex. A portion of fibres cross the midline to the 
contralateral cochlea while others project to the ipsilateral cochlea both via the vestibular 
nerves (Guinan Jr, 2006). Within the cochlea the MOC fibres innervate the outer hair cells; 
this is referred to as the medial olivocochlear system (MOCS). The MOCS is innervated by 
ascending and descending neural pathways. Descending innervations arises from the 
inferior colliculus and auditory cortex (Mulders & Robertson, 2000a; Mulders & Robertson, 
2000b).  
Ascending innervation arises predominantly from the contralateral cochlea, by way of inter-
neurons which cross the brainstem from cochlear nucleus to the olivary complex (Brown, 
Venecia, & Guinan, 2003; Morest, 1973; Ye, Machado, & Kim, 2000). The majority of MOCS 
fibres cross back over the midline to innervate the cochlea from which innervation is 
received (Azeredo et al., 1999; M. Liberman & Brown, 1986). A smaller proportion of MOCS 
fibers do not travel back across the brainstem and therefore innervate the cochlea on the 
same side. As they are stimulated by signals from the contralateral ear they provide a 
mechanism by which stimulation of one ear can influence the detection of acoustic signals 
by the other ear (Azeredo et al., 1999; Warren III & Liberman, 1989a).  
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4.2 Physiology of the olivocochlear pathway 
Despite decades of investigation since the discovery of the olivocochlear pathway, 
understanding of its purpose remains somewhat speculative (Rasmussen, 1946). Proposed 
roles include protection against noise-induced hearing loss, enhancement of discrimination 
of sound in noise, or a role predominantly during development of the auditory pathway 
(Micheyl, Khalfa, Perrot, & Collet, 1997; Rajan & Johnstone, 1988; Walsh, McGee, McFadden, 
& Liberman, 1998).  
There are a few studies of inter-cochlear interaction in humans which are consistent with 
MOCS functioning to reduce sensitivity of the cochlea to auditory stimuli. For example, 
contralateral pure tone stimulation causes a reduction of compound action potentials 
(Folsom & Owsley, 1987). Contralateral narrow band noise causes a ‘negativation’ of the 
summating potential response to ipsilateral tone bursts (i.e. the negative amplitude of 
summating potential increases) (Innitzer & Ehrenberger, 1977). There are indications that 
cortical function (e.g. visual or auditory attention tasks) influences olivocochlear activity via 
descending neural pathways (Froehlich, Collet, & Morgon, 1993; Maison, Durrant, 
Gallineau, Micheyl, & Collet, 2001). 
Much more information on olivocochlear function has come from electrophysiological 
studies in animal models. Various investigations have supported the conclusion that MOCS 
activity turns down the gain of the cochlear amplifier (Siegel & Kim, 1982). The cochlear 
amplifier is an active process within the cochlea in which motor activity of OHCs increases 
sensitivity of the cochlea, by amplification of the basilar membrane motion induced by 
acoustic energy. With electrical stimulation of the olivocochlear bundle (OCB) in the floor of 
4th ventricle, the amplitude of the compound action potential of the auditory nerve induced 
by auditory stimuli is reduced (Galambos, 1956; Nieder & Nieder, 1970; Wiederhold & 
Peake, 1966). In this way, the threshold of the auditory nerve can be increased by as much as 
25dB  an effect referred to as the ‘level shift’ (Galambos, 1956). By using focal simulation 
near the cell bodies of olivocochlear fibers, it has been shown that MOCS mediates this effect 
(i.e., via action on OHCs), rather than LOCS (Gifford & Guinan Jr, 1987). Electrical 
stimulation of the OCB increases the cochlear microphonic and causes a decrease in the 
electrical impedance of scala media of the guinea pig (Mountain, Daniel Geisler, & 
Hubbard, 1980). These changes are considered to be due to hyperpolarization of outer hair 
cells (Art, Fettiplace, & Fuchs, 1984; Mountain et al., 1980). Thus electrical stimulation of 
MOCS suppresses OHC activity so dampening basilar membrane motion and reducing 
cochlear amplification. This has an indirect effect on IHC activity, as demonstrated by the 
level shift. 
Contralateral acoustic stimulation (CAS) has been found to elicit similar effects to electrical 
stimulation of the MOCS. This was first reported by Fex, who found that CAS increased the 
cochlear microphonic (Fex, 1962). Recording from the round window in cats, Liberman 
showed that the compound action potential generated by ipsilateral tone pips was 
suppressed by contralateral noise or tones. Sectioning of the olivocochlear bundle in the 
floor of 4th ventricle or in the inferior vestibular nerve abolished this contralateral 
suppression effect (M. C. Liberman, 1989; Warren III & Liberman, 1989b). Such studies 
clearly show that the MOCS is stimulated by ascending signals from the auditory 
pathway.  
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Descending neural pathways also contribute to the MOCS. This has been shown in humans 
by increased MOCS activity when attention is focused on acoustic signals (Maison, Micheyl, 
& Collet, 2001). Animal studies have shown that electrical stimulation of the inferior 
colliculus increases MOCS activity (Mulders & Robertson, 2000a; Scates, Woods, & Azeredo, 
1999). Axonal transport studies also suggest that MOCS neurons are innervated directly by 
neurons arising in the auditory cortex (Mulders & Robertson, 2000b). Though giving insight 
into olivocochlear activity electrophysiological studies have many limitations (Collet et al., 
1990). Sectioning experiments, especially at the level of the floor of 4th ventricle, are 
imprecise and are not fully selective for efferents (though their effectiveness has been 
carefully demonstrated (M. C. Liberman, 1989; Warren III & Liberman, 1989b)). Electrical 
stimuli provide global stimulation, and in the floor of the 4th ventricle may simulate both 
crossed and uncrossed medial efferents that loop close to the midline (however, the LOCS is 
probably less easily stimulated this way as its fibers are unmyelinated). The main 
disadvantage with electrical stimulation is that it does not necessarily reflect normal 
cochlear input/output activity. Stimulation is often at supraphysiological levels, and 
provides unnatural synchronization and frequency of stimulation. Results can be 
confounded by stimulation artifact. Also neither sectioning nor electrical stimulation can be 
applied to humans, which limits extrapolation of findings from the animal models. The 
opportunity to study the MOCS non-invasively in animal models and humans was 
facilitated by the discovery of otoacoustic emissions (OAEs) (Kemp, 1978a). 
The function of the LOCS is not well understood. Some groups have proposed a role in 
providing “binaural balance” for sound localization has been proposed (Darrow, Maison, & 
Liberman, 2006; Guinan Jr, 2006). Studies to confirm this hypothesis are still needed. 
5. New technology 
5.1 Frequency specificity in the Medial Olivocochlear System (MOCS) 
It is now well established that the sensitivity and frequency tuning of the peripheral 
auditory system is influenced by the cochlear efferent neural pathways (Guinan Jr, 2006). 
Activation of the MOCS by acoustic stimulation of the contralateral ear has been shown to 
suppress sensitivity of the cochlea, for example by reduction in cochlear nerve action 
potential amplitude (Fex, 1962). It is considered that this effect is mediated by suppression 
of the cochlear amplifier effect of OHC activity (Siegel & Kim, 1982). It is likely that 
relatively specific stimulus conditions are required for efferents to play a role in hearing 
(M. C. Liberman, 1988), but despite intensive investigation, the nature of this role remains 
unclear. Further assessment of how the MOCS is activated by different stimuli should 
improve understanding of this issue (Maison, Micheyl, Andéol, Gallégo, & Collet, 2000).  
Tonotopicity of the MOCS has been clearly demonstrated in recordings from single 
olivocochlear fibers in the cat and guinea pig (Brown, 1989; Cody & Johnstone, 1982; M. 
Liberman & Brown, 1986). In these studies, efferent neural tuning curves were derived by 
measuring firing rate in response to contralateral tones of different frequency, and were 
found to have a shape and sharpness similar to cochlear afferent tuning curves. In 
addition, horseradish peroxidase injection was used to reveal the projection of some 
fibers, and in all cases they terminated on OHCs at a cochlear position where afferent 
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neurons have a characteristic frequency (CF) similar to that measured in the cochlear 
efferent.  
Frequency specificity of MOCS activity can also be detected when recording the response of 
inner hair cells and auditory nerve fibers to acoustic stimulation. For example in cats, the 
response of single cochlear afferent fibers to tone pips is suppressed by simultaneously 
applying tone pips to the contralateral ear. This suppression is maximal when the 
contralateral tone is similar to the characteristic frequency of the afferent fiber (Murata, 
Tanahashi, Horikawa, & Funai, 1980; Warren III & Liberman, 1989a; Warren III & Liberman, 
1989b). Similarly, when recording the compound action potential induced by tone pips with 
a round window electrode, maximum suppression is induced by contralateral tone pips of 
similar frequency (M. C. Liberman, 1989).  
As OAEs are generated by OHC activity, they may provide a more direct and non-invasive 
insight into the effect of the MOCS on its target cells than neural recordings. In human 
subjects, suppression of spontaneous OAEs is maximal with a CAS tone at a frequency close 
to the spontaneous OAE  (Mott, Norton, Neely, & Bruce Warr, 1989). In addition to 
suppression, a frequency shift of spontaneous OAEs is caused by CAS and interestingly this 
is maximal with a CAS about 3/8 to 1/2 octaves below the spontaneous OAE frequency. 
OAEs evoked by tone pips can be suppressed by contralateral narrow band noise, 
suppression being maximal with CAS frequencies close to the frequency of the tone pip 
(Veuillet, Collet, & Duclaux, 1991).  
Contralateral suppression of OAEs has not been widely used to investigate MOCS 
frequency specificity in animal models. A systematic study in the barn owl produced 
frequency response functions in which DPOAE suppression was plotted as a function of 
CAS frequency (Manley, Taschenberger, & Oeckinghaus, 1999). This showed maximal 
suppression with CAS similar to primary frequencies. Extrapolation of these findings to 
other models is limited by the variability of DPOAE levels and the additional types of 
efferent fiber which are present in birds.  
The purpose of the present study was to investigate the frequency specificity of the MOCS 
in the chinchilla. In this species there has been a report of difficulty in detecting MOCS 
change in response to contralateral stimulation (Azeredo et al., 1999). On the other hand, 
electrical stimulation of the olivocochlear bundle in the floor of the fourth ventricle elicits 
OAE suppression (Siegel & Kim, 1982). In our present study, the suppressive effect on 
DPOAEs of contralateral pure tone stimuli is investigated with real-time recording of the 
DPOAE.  
5.1.1 Materials and methods 
5.1.1.1 Animals  
Ten anaesthetized adult chinchillas (Chinchilla laniger) weights 505 - 725 g were studied. 
The anesthetic regime was intra-peritoneal Ketamine 15mg/kg (Ketamine Hydrochloride 
U.S.P. 100mg/ml, Ayerst Laboratories, Ontario), Xylazine 2.5mg/kg (Xylazine 20mg/ml, 
Bayer Inc., Toronto), and Atropine 0.04mg/kg (Atropine Sulfate 0.5mg/ml, MTC 
Pharmaceuticals, Ontario). Recordings were started 15 minutes after induction of anesthesia. 
A second dose of anesthetic was given 45 minutes later (intra-peritoneal Ketamine 8mg/kg, 
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Xylazine 1.3mg/kg). Five animals were studied twice, typically with an interval of >4 weeks 
between recording sessions. Thus in total, 15 recording sessions were completed. All studies 
were approved by the local Animal Care Committee, following the guidelines of the 
Canadian Council on Animal Care. 
5.1.1.2 Real time DPOAE measurement  
DPOAEs were measured in real time with a Vivo 600 DPR device (Vivosonic Inc., Toronto, 
ON). In contrast to conventional OAE techniques which employ signal averaging to extract 
the signal from noise, this technique uses digital filtering and signal modeling. The 
continuous real-time signal is ideally suited to the detection of changes in OAE amplitude, 
such as those produced by contralateral stimuli (James et al., 2005). Primary frequencies 
were set at f2/f1= 1.22 for values of f2 between 1.6 and 8.0 kHz, with intensities of L1 = 70dB 
and L2 = 65dB. DPOAEs were measured at 2f1-f2. The OAE probe, in a conforming soft 
plastic cuff, was inserted into the external auditory meatus by straightening the soft tissues 
to allow the probe to abut the lateral aspect of the bony meatus (approximately 13mm from 
the tympanic membrane). Multiple recordings of up to three minutes duration were made in 
each session. All recordings were made in a sound-attenuating booth. The DPOAE probe 
was calibrated in the ear canal by the device and calibration confirmed in a 2ml coupler 
using an SR760 FFT Spectrum Analyzer (Stanford Research Systems, Sunnyvale, CA) and a 
precision CR: 511D Acoustic Calibrator (Cirrus Research plc, North Yorkshire, U.K.).  
5.1.1.3 Contralateral stimulus  
An intermittent pure tone stimulus was applied to the contralateral ear using an ER-2 
transducer with a foam ear-insert (Etymotic Research Inc., IL). 60 different CAS frequencies 
were tested between 0.6 – 17 kHz. Sweep direction from high to low, or low to high 
frequency of contralateral stimulation was changed between sweeps to control for any 
gradual drift in DPOAE level that might occur during a recording period. CAS intensity was 
set at 50 dB SPL as a previous study had shown the threshold for a response to be around 
30dB SPL while acoustic cross talk occurred at intensities of ≥70 dB SPL (using noise floor 
measures and recordings in cadaveric chinchilla). Stimulus duration was set at 0.5s with rise 
/ fall times of 4 ms. The interval between stimuli was long enough to allow DPOAE levels to 
return to pre-stimulus levels (typically > 300ms longer than CAS duration).  
5.1.1.4 Analysis of results  
DPOAE signals were recorded in real time, and level changes occurring in synchrony with 
contralateral stimulation were noted. Subsequent analysis was performed on the recorded 
real time trace and on averaged data, using VivoAnalysis software (Vivosonic Inc., ON), 
based on LabVIEW 5.1 data acquisition software (National Instruments, TX). Averaging was 
synchronized with the start of the CAS and was used to smooth the data and remove non-
synchronous or spontaneous variation in the DPOAE signal. Averaged data were used to 
measure the magnitude of the DPOAE response to CAS from the baseline (no contralateral 
stimulation condition) to maximum OAE change (i.e. at asymptotic level). Frequency 
response curves to indicate tuning of contralateral suppression were plotted with 
magnitude of suppression (dependent variable) versus frequency of CAS tone (independent 
variable).  
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5.1.2 Results  
DPOAEs were successfully recorded in real time in all animals. DPOAE levels were stable 
for the duration of the experiments, though they tended to fall gradually around 2 – 4 
dB/hr. Figures 1 through 5 demonstrate DPOAE suppression data progressing from the 
initial real time signal, to the averaged waveform, and finally ideal curve fitting to the 
contralateral frequency response function.  
 
Fig. 1. Typical example of contralateral suppression of real time DPOAE signals in 
chinchilla: (a) DPOAE at f2 = 4.4 kHz, contralateral acoustic stimulation = 5.9 kHz at 50dB 
SPL; (b) DPOAE at f2 = 7.7 kHz, contralateral acoustic stimulation = 8.4 kHz at 50 dB SPL. 
(Stimulus duration = 550ms, marked by horizontal black bar).  
Figure 1 shows examples of real time recordings of DPOAE suppression. Panel 1a shows 
variation in DPOAE level at f2 = 4.4 kHz over a twelve second period during six periods of 
CAS at 5.9 kHz (marked by horizontal bar). Suppression of 0.5 dB from the baseline level of 
38.8 dB SPL occurs with each CAS. In panel 1b, a DPOAE at f2 = 7.7 kHz is suppressed by 1.2 
dB by CAS of 8.4 kHz. The suppression response was sometimes smaller than the 
spontaneous signal variation so was not always readily visible in real-time. However, by 
averaging the raw real-time data in synchrony with the onset of CAS, suppression could 
usually be detected.  
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Typical examples of averaged DPOAE suppression responses are shown in figure 2. Here 
the DPOAE measured is at f2 = 4.4 kHz, with contralateral suppression stimuli between 2.8 
and 6.7 kHz. In this series, suppression is greatest (0.8 dB) with contralateral stimulations at 
4.5 kHz, but is only half this value when contralateral stimulation is at 2.8 kHz or 6.7 kHz, 
indicating the frequency dependence of DPOAE suppression.  
 
Fig. 2. Averaged DPOAE signal from 20s recording periods, synchronized with onset of 
contralateral stimulus. (DPOAE at f2 = 4.4 kHz; contralateral acoustic stimulation at 
frequencies of 2.8 – 6.7 kHz (550ms duration, as black bar).  
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Fig. 3. DPOAE suppression plotted against contralateral stimulation frequency. Panels a – f 
show suppression response measured from single animal recordings at DPOAE frequencies 
ranging from f2 of 1.6 kHz to 7.7 kHz.  
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Fig. 4. Contralateral suppression frequency response curve for DPOAE of f2 = 4.4 kHz 
(marked by vertical dotted line), derived from pooling data from 8 animals. Bars show 95% 
confidence intervals.  
The frequency response function for f2 = 4.4 kHz in figure 4 was derived from 22 recordings 
in eight animals. Mean suppression was plotted against CAS frequency. The large 95% 
confidence intervals reflect the variability of response in different experiments. However, as 
in figure 3, the curve peaks near the f2 frequency (dotted line).  
In figure 3, magnitude of contralateral suppression is plotted against CAS frequency for six 
different DPOAE frequencies. The curves peak close to the f2 value (marked by the dotted 
line) but typically peak suppression magnitude occurs at a frequency slightly higher than f2. 
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In an attempt to reduce the variability of the response between recordings and to obtain 
finer details on the shape of the frequency response, repeated measures from CAS close to f2 
were made in successive recordings in one chinchilla. The results are shown in figure 5. 
Even within this single recording period in an individual animal, variability (up to 0.15dB) 
can be seen in successive sweeps. No repeatable notches in the curve were visible.  
As illustrated in figure 5 by the continuous line, the general shape of the DPOAE 
suppression tuning can be characterized by fitting a regression curve to the data. In figure 6, 
the same regression function is plotted for four values of f2 between 3.1 – 7.7 kHz using data 
combined from multiple recordings. The responses are asymmetric with a tendency to drop 
off more steeply at values of CAS greater than f2. Small suppression responses can be 
obtained by CAS tones more than one octave lower than the f2 frequency.  
 
Fig. 5. Contralateral suppression frequency response curve for DPOAE of f2 = 4.4 kHz 
derived from one subject. Dashed line is mean value. Solid line is regression curve 
(Weibull). 
In figure 7, the suppression curves of fig. 6 are plotted on a normalized amplitude scale. The 
curves are broadly tuned and thus there is considerable overlap. The tuning of suppression 
curves for high frequency DPOAEs is narrower than at lower frequencies. The (half-
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amplitude) bandwidth values for suppression curves at 3.1, 4.4, 5.4, 6.6, and 7.7 kHz (f2) are, 
respectively, 1.7, 1.8, 1.4, 1.15, and 1.3 octaves.  
DPOAE suppression was seen in all animals with contralateral pure tone stimulation. On 
rare occasions, CAS induced an increase in DPOAE level. This occurred at f2 = 2.2 kHz in 
one chinchilla and at f2 = 6.6 and 7.7 kHz in another. The maximum response occurred with 
a contralateral tone at or just below the frequency of f2. These data were excluded from 
analysis as they may represent a different process. 
 
Fig. 6. Regression functions (Weibull) of DPOAE suppression frequency response curves for 
four values of f2 between 3.1 and 7.7 kHz. Curves are plotted on an absolute dB suppression 
scale.  
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Fig. 7. DPOAE suppression frequency response curves (Weibull regressions) for f2 values 
between 3.1 and 7.7 kHz, plotted on a normalized suppression scale (data from figs 4 and 6). 
5.1.3 Discussion 
This study demonstrates that suppression of DPOAEs by contralateral pure tones can be 
detected in the chinchilla with real time recording. DPOAE suppression is greatest when 
using contralateral stimulation tones close to primary tone f2. This tonotopic response is 
consistent with other investigations of frequency specificity in the MOCS pathway  (Chery-
Croze, Moulin, & Collet, 1993; Cody & Johnstone, 1982; M. C. Liberman, 1989; Murata et al., 
1980; Robertson, 1984; Robertson & Gummer, 1985; Veuillet et al., 1991; Warren III & 
Liberman, 1989a; Warren III & Liberman, 1989b). Unlike observations in human subjects, we 
did not observe any dips in fine structure DPOAEs to account for differences in the 
magnitude of suppression at different values of f2 or between chinchillas (Wagner, 
Heppelmann, Müller, Janssen, & Zenner, 2007).  
Measurement of contralateral frequency tuning of MOCS fibers has revealed narrow band 
tuning equivalent in sharpness to cochlear afferent neurons (Brown, 1989; M. Liberman & 
Brown, 1986; Robertson, 1984). The final, divergent innervation pattern of MOCS fibers at 
the OHC level appears to degrade this cochleotopicity (or frequency tuning) by a factor of 4-
5 from 0.33 octaves (the approximate bandwidth of auditory afferents) to about 1.7 octaves 
for f2 = 3.1kHz and 1.3 octaves for f2 = 7.7kHz. The difference in tuning likely rests with the 
divergent OHC innervation by the MOCS fibers. Neural tracing studies in guinea pig have 
shown MOCS fibers innervating 15 -61 OHCs (Brown, 1989). In the cat, individual cochlear 
efferents contact 23 – 84 OHCs spanning 0.55-2.8mm (M. Liberman & Brown, 1986). Thus 
although tuning in the efferent fibers themselves appears to be as sharp as afferent tuning, 
the effect of individual fibers on the organ of Corti will be much less precise.  
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MOCS frequency tuning has been assessed in the cat by recording changes in single afferent 
fiber activity during CAS. Suppression of afferent firing rate is maximal with a CAS of 
similar frequency to the characteristic frequency of the afferent fiber  (Warren III & 
Liberman, 1989a; Warren III & Liberman, 1989b)). Tuning of this form of contralateral 
suppression was asymmetric, falling off more sharply at CAS frequencies above 
characteristic frequency, and were much less sharp than afferent tuning. Tuning tended to 
be sharper at higher frequencies. These observations in the cat are consistent with the 
contralateral DPOAE suppression tuning reported here for the chinchilla, where 
bandwidths for curves at 6.6 and 7.7 kHz (f2) are 1.15 and 1.3 octaves respectively, but are 
1.7 and 1.8 octaves at 3.1 and 4.4 kHz.  
As shown by others, the primary tones used to generate DPOAE stimulate the MOCS and so 
cause ipsilateral DPOAE suppression (Guinan, Backus, Lilaonitkul, & Aharonson, 2003; M. 
C. Liberman, Puria, & Guinan Jr., 1996). It can be expected that the primary tones would 
suppress cochlear function in the contralateral ear by MOCS activation, with the same broad 
frequency tuning that we have observed. Given that the magnitude of contralateral 
suppression of DPOAE is dependent upon intensity of the contralateral stimulus (A. James, 
Mount, & Harrison, 2002), a hypothetical outcome would be a notch in the frequency 
response curve at the primary frequencies, f1 and f2. This has been observed at f1 in the barn 
owl but despite thorough investigation at one frequency (f2 = 4.4kHz, figure 5), we were 
unable to demonstrate this phenomenon in the chinchilla (Manley et al., 1999).  
As in other studies, recordings were completed under anesthesia with ketamine and 
xylazine. This does reduce the magnitude of contralateral suppression of DPOAE and other 
measures of olivocochlear function but facilitates recording by providing stable recording 
conditions, with less behavioral noise and movement artifact (Cazals & Huang, 1996; da 
Costa, Erre, de Sauvage, Popelar, & Aran, 1997; Harel, Kakigi, Hirakawa, Mount, & 
Harrison, 1997). We have not investigated the effect of anesthesia on tuning sharpness. 
As mentioned previously the exact function of the medial olivo-cochlear system remains 
speculative. Because of the predominantly inhibitory effect seen on outer hair cell function, 
improved detection of sound in noise or a protective effect have been hypothesized. Any 
role postulated for the contralateral suppression response should take into account the 
relatively slow dynamic of this reflex, being of the order of 26ms in chinchilla and 45ms in 
humans (James, Harrison, Pienkowski, Dajani, & Mount, 2005). The presence of a response 
from low intensity contralateral stimuli suggests the function of this system is less likely a 
protective one, but more to do with frequency tuning of the afferent neural responses via 
efferent effects on OHC motility. The efferent system may function as a gain control with a 
long time-constant, equalizing sensitivity between the ears. The optimal condition for 
detecting inter-aural timing or intensity differences would perhaps be when the two ears 
have equivalent function. In this respect, the medial contralateral efferent system may also 
have a role in “balancing” the ears such as to improve the accuracy of these binaural sound 
localization tasks.  
6. Conclusions 
Objective tests such as OAE and ABR are widely used in hearing screening programs and 
have lead to great advances in the early detection and rehabilitation of neonatal hearing 
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loss. However these tests do not provide a quick and easy means for assessing hearing 
threshold at different frequencies, indeed the presence of OAE does not even guarantee the 
presence of normal hearing. An objective frequency specific test of hearing ability would 
have widespread advantages, not just for neonatal testing but in many circumstances in all 
age groups.  
In the present study we have demonstrated frequency specificity in contralateral 
suppression using a chinchilla model. The majority of studies shedding light onto the 
function of the MOCS have been derived from animal experiments. However, there is 
enough data in human studies to suggest that the human efferent system is qualitatively 
similar (Guinan Jr, 2006; James, 2006). We have shown previously that contralateral 
suppression of DPOAE can be assessed in real time in babies and adults (James et al., 2005) 
and can be used to test hearing very effectively in neonates (James, 2011). We have shown 
that this technique can distinguish between middle ear muscle reflexes and the OCR in an 
animal model (Wolter, Harrison, & James, 2011) and here show that it can be used to assess 
hearing threshold in a frequency specific manner. We envisage many clinical applications of 
this technique including the diagnosis and assessment of ANSD and more accurate hearing 
screening in neonatal and elderly populations. 
7. References  
Allen, T. E. (1986). Patterns of academic achievement among hearing impaired students: 
1974 and 1983. In K. A. Schildroth A (Ed.), Deaf children in america (pp. 161-206) San 
Diego: College-Hill Press.  
Amatuzzi, M. G., Northrop, C., Liberman, M. C., Thornton, A., Halpin, C., Herrmann, B., et 
al. (2001). Selective inner hair cell loss in premature infants and cochlea 
pathological patterns from neonatal intensive care unit autopsies. Archives of 
Otolaryngology- Head and Neck Surgery, 127(6), 629.  
Art, J., Fettiplace, R., & Fuchs, P. (1984). Synaptic hyperpolarization and inhibition of turtle 
cochlear hair cells. The Journal of Physiology, 356(1), 525.  
Attias, J., & Raveh, E. (2007). Transient deafness in young candidates for cochlear implants. 
Audiology and Neurotology, 12(5), 325-333.  
Azeredo, W. J., Kliment, M. L., Morley, B. J., Relkin, E., Slepecky, N. B., Sterns, A., et al. 
(1999). Olivocochlear neurons in the chinchilla: A retrograde fluorescent labelling 
study. Hearing Research, 134(1-2), 57-70.  
Berlin, C. I., Hood, L. J., Morlet, T., Wilensky, D., St. John, P., Montgomery, E., et al. (2005). 
Absent or elevated middle ear muscle reflexes in the presence of normal 
otoacoustic emissions: A universal finding in 136 cases of auditory 
neuropathy/dys-synchrony. Journal of the American Academy of Audiology, 16(8), 546-
553.  
Brown, M. (1989). Morphology and response properties of single olivocochlear fibers in the 
guinea pig. Hearing Research, 40(1-2), 93-109.  
Brown, M., Venecia, R. K., & Guinan, J. (2003). Responses of medial olivocochlear neurons. 
Experimental Brain Research, 153(4), 491-498.  
Busa, J., Harrison, J., Chappell, J., Yoshinaga-Itano, C., Grimes, A., Brookhouser, P. E., et al. 
(2007). Year 2007 position statement: Principles and guidelines for early hearing 
detection and intervention programs. Pediatrics, 120(4), 898-921.  
www.intechopen.com
Contralateral Suppression of Otoacoustic Emissions:  
Working Towards a Simple Objective Frequency Specific Test for Hearing Screening 
 
45 
Cazals, Y., & Huang, Z. (1996). Average spectrum of cochlear activity: A possible 
synchronized firing, its olivo-cochlear feedback and alterations under anesthesia. 
Hearing Research, 101(1-2), 81-92.  
Chery-Croze, S., Moulin, A., & Collet, L. (1993). Effect of contralateral sound stimulation on 
the distortion product 2f1-f2 in humans: Evidence of a frequency specificity. 
Hearing Research, 68(1), 53-58.  
Choo, D., & Meinzen-Derr, J. (2010). Universal newborn hearing screening in 2010. Current 
Opinion in Otolaryngology & Head and Neck Surgery, 18(5), 399.  
Cody, A., & Johnstone, B. (1982). Acoustically evoked activity of single efferent neurons in 
the guinea pig cochlea. The Journal of the Acoustical Society of America, 72, 280.  
Collet, L., Kemp, D. T., Veuillet, E., Duclaux, R., Moulin, A., & Morgon, A. (1990). Effect of 
contralateral auditory stimuli on active cochlear micro-mechanical properties in 
human subjects. Hearing Research, 43(2-3), 251-261.  
Cone-Wesson, B., Rance, G., & Sininger, Y. (2001). For patients with auditory neuropathy. In 
Y. S. Sininger, & A. Starr (Eds.), Auditory neuropathy: A new perspective on hearing 
disorders (pp. 233). San Diego: Singular Pub Group.  
da Costa, D. L., Erre, J. P., de Sauvage, R. C., Popelar, J., & Aran, J. M. (1997). Bioelectrical 
cochlear noise and its contralateral suppression: Relation to background activity of 
the eighth nerve and effects of sedation and anesthesia. Experimental Brain Research, 
116(2), 259-269.  
Darrow, K. N., Maison, S. F., & Liberman, M. C. (2006). Cochlear efferent feedback balances 
interaural sensitivity. Nature Neuroscience, 9(12), 1474.  
Davis, A., & Wood, S. (1992). The epidemiology of childhood hearing impairment: Factors 
relevant to planning of services. British Journal of Audiology, 26(2), 77-90.  
Davis, A., Bamford, J., Wilson, I., Ramkalawan, T., Forshaw, M., & Wright, S. (1997). A 
critical review of the role of neonatal hearing screening in the detection of 
congenital hearing impairment. Health Technology Assessment (Winchester, England), 
1(10), i-iv, 1-176.  
Fex, J. (1962). Auditory activity in centrifugal and centripetal cochlear fibres in cat. A study 
of a feedback system. Acta Physiologica Scandinavica.Supplementum, 189, 1-68.  
Folsom, R. C., & Owsley, R. M. (1987). N1 action potentials in humans: Influence of 
simultaneous contralateral stimulation. Acta Oto-Laryngologica, 103(3-4), 262-265.  
Froehlich, P., Collet, L., & Morgon, A. (1993). Transiently evoked otoacoustic emission 
amplitudes change with changes of directed attention. Physiology & Behavior, 53(4), 
679-682.  
Galambos, R. (1956). Suppression of auditory nerve activity by stimulation of efferent fibers 
to cochlea. Journal of Neurophysiology, 19(5), 424.  
Gifford, M. L., & Guinan Jr, J. J. (1987). Effects of electrical stimulation of medial 
olivocochlear neurons on ipsilateral and contralateral cochlear responses. Hearing 
Research, 29(2-3), 179-194.  
Gold, T. (1948). Hearing. II. the physical basis of the action of the cochlea. Proceedings of the 
Royal Society of London.Series B, Biological Sciences, , 492-498.  
Guinan Jr, J. J. (2006). Olivocochlear efferents: Anatomy, physiology, function, and the 
measurement of efferent effects in humans. Ear and Hearing, 27(6), 589.  
Guinan, J. J., Backus, B. C., Lilaonitkul, W., & Aharonson, V. (2003). Medial olivocochlear 
efferent reflex in humans: Otoacoustic emission (OAE) measurement issues and the 
www.intechopen.com
 
Hearing Loss 
 
46
advantages of stimulus frequency OAEs. JARO-Journal of the Association for Research 
in Otolaryngology, 4(4), 521-540.  
Hall, J. W., Smith, S. D., & Popelka, G. R. (2004). Newborn hearing screening with combined 
otoacoustic emissions and auditory brainstem responses. Journal of the American 
Academy of Audiology, 15(6), 414-425.  
Harel, N., Kakigi, A., Hirakawa, H., Mount, R. J., & Harrison, R. V. (1997). The effects of 
anesthesia on otoacoustic emissions. Hearing Research, 110(1-2), 25-33.  
Harrison, R. V. (1998). An animal model of auditory neuropathy. Ear and Hearing, 19(5), 355.  
Harrison, R. V. (2001). Models of auditory neuropathy based on inner hair cell damage. In Y. 
S. Sininger, & A. Starr (Eds.), (pp. 51–66). San Diego: Singular.  
Hecox, K., & Galambos, R. (1974). Brain stem auditory evoked responses in human infants 
and adults. Archives of Otolaryngology- Head and Neck Surgery, 99(1), 30.  
Holden-Pitt, L., & Albertorio, J. (1998). Thirty years of the annual survey of deaf and hard-
of-hearing children & youth: A glance over the decades. American Annals of the Deaf, 
143(2), 72-76.  
Hood, L. J., & Berlin, C. I. (2001). In Sininger Y. S., Starr A. (Eds.), Auditory neuropathy 
(auditory dys-synchrony) disables efferent suppression of otoacoustic emissions. San 
Diego: Singulair.  
Innitzer, J., & Ehrenberger, K. (1977). The influence of contralateral acoustic stimulation on 
the summating potential in the human cochlea. [DER EINFLUSS 
KONTRALATERALER BESCHALLUNG AUF DAS SUMMATIONSPOTENTIAL 
DER MENSCHLICHEN KOCHLEA] Laryngologie Rhinologie Otologie, 56(11), 921-
924.  
Jacobson, J., & Jacobson, C. (2004). Evaluation of hearing loss in infants and young children. 
Pediatric Annals, 33(12), 811-821.  
James, A. L. (2006). Real time measurement of distortion product otoacoustic emissions in the 
assessment of the olivocochlear contralateral reflex. Unpublished  
James, A. L. (2011). The assessment of olivocochlear function in neonates with real‐time 
distortion product otoacoustic emissions. The Laryngoscope, 121(1), 202-213.  
James, A. L., Harrison, R. V., Pienkowski, M., Dajani, H. R., & Mount, R. J. (2005). Dynamics 
of real time DPOAE contralateral suppression in chinchillas and humans dinámica 
de la supresión contralateral de las DPOAE en tiempo real en chinchillas y 
humanos. International Journal of Audiology, 44(2), 118-129.  
James A. L., Mount, R., & Harrison, R. (2002). Contralateral suppression of DPOAE 
measured in real time. Clinical Otolaryngology & Allied Sciences, 27(2), 106-112.  
Kemp, D. T. (1978a). Stimulated acoustic emissions from within the human auditory system. 
Journal of the Acoustical Society of America, 64(5), 1386-1391.  
Kemp, D. T. (1978b). Stimulated acoustic emissions from within the human auditory system. 
Journal of the Acoustical Society of America, 64(5), 1386-1391.  
Kennedy, C., McCann, D., Campbell, M. J., Kimm, L., & Thornton, R. (2005). Universal 
newborn screening for permanent childhood hearing impairment: An 8-year 
follow-up of a controlled trial. The Lancet, 366(9486), 660-662.  
Kimura, R., & Wersäll, J. (1962). Termination of the olivo-cochlear bundle in relation to the 
outer hair cells of the organ of corti in guinea pig. Acta Oto-Laryngologica, 55(1-6), 
11-32.  
www.intechopen.com
Contralateral Suppression of Otoacoustic Emissions:  
Working Towards a Simple Objective Frequency Specific Test for Hearing Screening 
 
47 
Kral, A., & O'Donoghue, G. M. (2010). Profound deafness in childhood. New England Journal 
of Medicine, 363(15), 1438-1450.  
Liberman, M. C. (1988). Response properties of cochlear efferent neurons: Monaural vs. 
binaural stimulation and the effects of noise. Journal of Neurophysiology, 60(5), 1779.  
Liberman, M. C. (1989). Rapid assessment of sound-evoked olivocochlear feedback: 
Suppression of compound action potentials by contralateral sound. Hearing 
Research, 38(1-2), 47-56.  
Liberman, M., & Brown, M. (1986). Physiology and anatomy of single olivocochlear neurons 
in the cat. Hearing Research, 24(1), 17-36.  
Liberman, M. C., Puria, S., & Guinan Jr., J. J. (1996). The ipsilaterally evoked olivocochlear 
reflex causes rapid adaptation of the 2f1-f2 distortion product otoacoustic emission. 
Journal of the Acoustical Society of America, 99(6), 3572-3584.  
Llanes, E. G. D. V., & Chiong, C. M. (2004). Evoked otoacoustic emissions and auditory 
brainstem responses: Concordance in hearing screening among high-risk children. 
Acta Oto-Laryngologica, 124(4), 387-390.  
Maison, S., Durrant, J., Gallineau, C., Micheyl, C., & Collet, L. (2001). Delay and temporal 
integration in medial olivocochlear bundle activation in humans. Ear and Hearing, 
22(1), 65.  
Maison, S., Micheyl, C., Andéol, G., Gallégo, S., & Collet, L. (2000). Activation of medial 
olivocochlear efferent system in humans: Influence of stimulus bandwidth. Hearing 
Research, 140(1-2), 111-125.  
Maison, S., Micheyl, C., & Collet, L. (2001). Influence of focused auditory attention on 
cochlear activity in humans. Psychophysiology, 38(1), 35-40.  
Manchaiah, V. K. C., Zhao, F., Danesh, A. A., & Duprey, R. (2011). The genetic basis of 
auditory neuropathy spectrum disorder (ANSD). International Journal of Pediatric 
Otorhinolaryngology, 75(2), 151-158.  
Manley, G. A., Taschenberger, G., & Oeckinghaus, H. (1999). Influence of contralateral 
acoustic stimulation on distortion-product and spontaneous otoacoustic emissions 
in the barn owl. Hearing Research, 138(1-2), 1-12.  
Marschark, M., & Wauters, L. (2008). Language comprehension and learning by deaf 
students. Deaf Cognition: Foundations and Outcomes, , 309–350.  
Micheyl, C., Khalfa, S., Perrot, X., & Collet, L. (1997). Difference in cochlear efferent activity 
between musicians and non-musicians. Neuroreport, 8(4), 1047.  
Moeller, M. P. (2000). Early intervention and language development in children who are 
deaf and hard of hearing. Pediatrics, 106(3), e43.  
Mohr, P. E., Feldman, J. J., Dunbar, J. L., McConkey-Robbins, A., Niparko, J. K., Rittenhouse, 
R. K., et al. (2000). The societal costs of severe to profound hearing loss in the 
united states. International Journal of Technology Assessment in Health Care, 16(4), 
1120-1135.  
Morest, D. (1973). Auditory neurons of the brain stem. Advances in Oto-Rhino-Laryngology, 
20, 337.  
Mott, J. B., Norton, S. J., Neely, S. T., & Bruce Warr, W. (1989). Changes in spontaneous 
otoacoustic emissions produced by acoustic stimulation of the contralateral ear. 
Hearing Research, 38(3), 229-242.  
www.intechopen.com
 
Hearing Loss 
 
48
Mountain, D. C., Daniel Geisler, C., & Hubbard, A. E. (1980). Stimulation of efferents alters 
the cochlear microphonic and the sound-induced resistance changes measured in 
scala media of the guinea pig. Hearing Research, 3(3), 231-240.  
Mulders, W., & Robertson, D. (2000a). Effects on cochlear responses of activation of 
descending pathways from the inferior colliculus. Hearing Research, 149(1-2), 11-23.  
Mulders, W., & Robertson, D. (2000b). Evidence for direct cortical innervation of medial 
olivocochlear neurones in rats. Hearing Research, 144(1-2), 65-72.  
Murata, K., Tanahashi, T., Horikawa, J., & Funai, H. (1980). Mechanical and neural 
interactions between binaurally applied sounds in cat cochlear nerve fibers. 
Neuroscience Letters, 18(3), 289-294.  
Nadol Jr, J. B. (2001). Primary cochlear neuronal degeneration. Auditory Neuropathy: A New 
Perspective on Hearing Disorders, , 99–140.  
Nieder, P. C., & Nieder, I. (1970). Crossed olivocochlear bundle: Electrical stimulation 
enhances masked neural responses to loud clicks. Brain Research, 21(1), 135-137.  
Rajan, R., & Johnstone, B. (1988). Binaural acoustic stimulation exercises protective effects at 
the cochlea that mimic the effects of electrical stimulation of an auditory efferent 
pathway. Brain Research, 459(2), 241-255.  
Rance, G., & Barker, E. J. (2008a). Speech perception in children with auditory 
neuropathy/dyssynchrony managed with either hearing aids or cochlear implants. 
Otology & Neurotology, 29(2), 179.  
Rance, G., & Barker, E. J. (2008b). Speech perception in children with auditory 
neuropathy/dyssynchrony managed with either hearing aids or cochlear implants. 
Otology & Neurotology, 29(2), 179.  
Rasmussen, G. L. (1946). The olivary peduncle and other fiber projections of the superior 
olivary complex. The Journal of Comparative Neurology, 84(2), 141-219.  
Rasmussen, G. L. (1953). Further observations of the efferent cochlear bundle. The Journal of 
Comparative Neurology, 99(1), 61-74.  
Raveh, E., Buller, N., Badrana, O., & Attias, J. (2007). Auditory neuropathy: Clinical 
characteristics and therapeutic approach. American Journal of Otolaryngology, 28(5), 
302-308.  
Robertson, D. (1984). Horseradish peroxidase injection of physiologically characterized 
afferent and efferent neurones in the guinea pig spiral ganglion. Hearing Research, 
15(2), 113-121.  
Robertson, D., & Gummer, M. (1985). Physiological and morphological characterization of 
efferent neurones in the guinea pig cochlea. Hearing Research, 20(1), 63-77.  
Saurini, P., Nola, G., & Lendvai, D. (2004). Otoacoustic emissions: A new method for 
newborn hearing screening. European Review for Medical and Pharmacological 
Sciences, 8, 129-133.  
Scates, K. W., Woods, C. I., & Azeredo, W. J. (1999). Inferior colliculus stimulation and 
changes in 2f1-f2 distortion product otoacoustic emissions in the rat. Hearing 
Research, 128(1-2), 51-60.  
Schroeder, L., Petrou, S., Kennedy, C., McCann, D., Law, C., Watkin, P. M., et al. (2006). The 
economic costs of congenital bilateral permanent childhood hearing impairment. 
Pediatrics, 117(4), 1101.  
Shapiro, S. M. (2003). Bilirubin toxicity in the developing nervous system. Pediatric 
Neurology, 29(5), 410-421.  
www.intechopen.com
Contralateral Suppression of Otoacoustic Emissions:  
Working Towards a Simple Objective Frequency Specific Test for Hearing Screening 
 
49 
Siegel, J. H., & Kim, D. (1982). Efferent neural control of cochlear mechanics? olivocochlear 
bundle stimulation affects cochlear biomechanical nonlinearity. Hearing Research, 
6(2), 171-182.  
Starr, A., Picton, T. W., Sininger, Y., Hood, L. J., & Berlin, C. I. (1996). Auditory neuropathy. 
Brain, 119(3), 741.  
Thompson, D. C., McPhillips, H., Davis, R. L., Lieu, T. A., Homer, C. J., & Helfand, M. 
(2001). Universal newborn hearing screening. JAMA: The Journal of the American 
Medical Association, 286(16), 2000.  
Veuillet, E., Collet, L., & Duclaux, R. (1991). Effect of contralateral acoustic stimulation on 
active cochlear micromechanical properties in human subjects: Dependence on 
stimulus variables. Journal of Neurophysiology, 65(3), 724-735.  
Wagner, W., Heppelmann, G., Müller, J., Janssen, T., & Zenner, H. -. (2007). Olivocochlear 
reflex effect on human distortion product otoacoustic emissions is largest at 
frequencies with distinct fine structure dips. Hearing Research, 223(1-2), 83-92.  
Wake, M., Hughes, E. K., Poulakis, Z., Collins, C., & Rickards, F. W. (2004a). Outcomes of 
children with mild-profound congenital hearing loss at 7 to 8 years: A population 
study. Ear and Hearing, 25(1), 1.  
Wake, M., Hughes, E. K., Poulakis, Z., Collins, C., & Rickards, F. W. (2004b). Outcomes of 
children with mild-profound congenital hearing loss at 7 to 8 years: A population 
study. Ear and Hearing, 25(1), 1.  
Walsh, E. J., McGee, J. A., McFadden, S. L., & Liberman, M. C. (1998). Long-term effects of 
sectioning the olivocochlear bundle in neonatal cats. The Journal of Neuroscience, 
18(10), 3859.  
Warr, W. B. (1975). Olivocochlear and vestibular efferent neurons of the feline brain stem: 
Their location, morphology and number determined by retrograde axonal 
transport and acetylcholinesterase histochemistry. The Journal of Comparative 
Neurology, 161(2), 159-181.  
Warren III, E. H., & Liberman, M. C. (1989a). Effects of contralateral sound on auditory-
nerve responses. I. contributions of cochlear efferents. Hearing Research, 37(2), 89-
104.  
Warren III, E. H., & Liberman, M. C. (1989b). Effects of contralateral sound on auditory-
nerve responses. II. dependence on stimulus variables. Hearing Research, 37(2), 105-
122.  
Wiederhold, M. L., & Peake, W. T. (1966). Efferent inhibition of auditory-nerve responses: 
Dependence on acoustic-stimulus parameters. Journal of the Acoustical Society of 
America,  
Wolter, N. E., Harrison, R. V., & James, A. L. (2011). Investigation of olivocochlear and 
middle ear muscle reflexes with contralateral suppression of DPOAEs in real time 
[Abstract]. Triological Society Eastern Section Annual Resident Competition - Podium 
Presentation,  
Yasunaga, S., Grati, M., Cohen-Salmon, M., El-Amraoui, A., Mustapha, M., Salem, N., et al. 
(1999). A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes 
DFNB9, a nonsyndromic form of deafness. Nature Genetics, 21(4), 363-369.  
Ye, Y., Machado, D., & Kim, D. (2000). Projection of the marginal shell of the anteroventral 
cochlear nucleus to olivocochlear neurons in the cat. The Journal of Comparative 
Neurology, 420(1), 127-138.  
www.intechopen.com
 
Hearing Loss 
 
50
Yoshinaga-Itano, C. (2003). Universal newborn hearing screening programs and 
developmental outcomes. Audiological Medicine, 1(3), 199-206.  
Yoshinaga-Itano, C., Sedey, A. L., Coulter, D. K., & Mehl, A. L. (1998). Language of early-
and later-identified children with hearing loss. Pediatrics, 102(5), 1161.  
www.intechopen.com
Hearing Loss
Edited by Dr. Sadaf Naz
ISBN 978-953-51-0366-0
Hard cover, 406 pages
Publisher InTech
Published online 28, March, 2012
Published in print edition March, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Authored by 17 international researchers and research teams, the book provides up-to-date insights on topics
in five different research areas related to normal hearing and deafness. Techniques for assessment of hearing
and the appropriateness of the Mongolian gerbil as a model for age-dependent hearing loss in humans are
presented. Parental attitudes to childhood deafness and role of early intervention for better treatment of
hearing loss are also discussed. Comprehensive details are provided on the role of different environmental
insults including injuries in causing deafness. Additionally, many genes involved in hearing loss are reviewed
and the genetics of recessively inherited moderate to severe and progressive deafness is covered for the first
time. The book also details established and evolving therapies for treatment of deafness.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Nikolaus E. Wolter, Robert V. Harrison and Adrian L. James (2012). Contralateral Suppression of Otoacoustic
Emissions: Working Towards a Simple Objective Frequency Specific Test for Hearing Screening, Hearing
Loss, Dr. Sadaf Naz (Ed.), ISBN: 978-953-51-0366-0, InTech, Available from:
http://www.intechopen.com/books/hearing-loss/contralateral-suppression-of-otoacoustic-emissions-working-
towards-a-simple-objective-frequency-spec
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
